Header Logo

Connection

MEGHANA TRIVEDI to Trastuzumab

Back to Details
This is a "connection" page, showing publications MEGHANA TRIVEDI has written about Trastuzumab.
MEGHANA TRIVEDI
Connection Strength
0.041
Trastuzumab
  1. Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy. Clin Cancer Res. 2020 02 01; 26(3):738-745.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.